BridgeBio Oncology Therapeutics, Inc. 4 filing

Filed 2025-08-13 · Report date 2025-08-11 · 2025

View Original SEC Filing

Filing metadata

Accession number: 0001213900-25-075305
Form type: 4
CIK: 0001869105
Primary document: https://www.sec.gov/Archives/edgar/data/1869105/000121390025075305/xslF345X05/ownership.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for BridgeBio Oncology Therapeutics, Inc..

Reported financial metrics

Metric	Current	Prior	Change